SUBSCRIBE
SUBSCRIBE

Espero BioPharma

IN THE PRESS
Drug Development
Espero BioPharma Assets Offered For Sale
June 25, 2020
 · 
1 min read
Business
Espero BioPharma, Inc. Expands Collaboration Effort for Tecarfarin
June 4, 2020
 · 
2 min read
Drug Development
Espero BioPharma Provides Corporate Update and 2018 Objectives
December 15, 2017
 · 
6 min read
Deals
Espero Pharma And Armetheon To Merge And Create A Premier Cardiovascular Focused Biopharmaceutical Company
March 31, 2017
 · 
6 min read
Deals
Espero Pharma Acquires DURLAZA (aspirin) Extended Release Capsules For Secondary Prevention Of Stroke And Acute Cardiac Events
February 7, 2017
 · 
5 min read
Espero Pharma Release: GONITRO To Participate In First-Of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial Sponsored By The NIH
January 19, 2017
 · 
3 min read
Espero Pharma Announces The Availability Of FDA-Approved GONITRO (Nitroglycerin) Sublingual Powder In The U.S.
September 27, 2016
 · 
2 min read
Business
Espero Pharma Selects DDB Health And Alamo Pharma Services As Partners For The Launch Of GONITRO (Nitroglycerin) Sublingual Powder
August 31, 2016
 · 
2 min read
FDA
Espero Pharma Receives FDA Approval For GONITRO (Nitroglycerin) Sublingual Powder
June 14, 2016
 · 
4 min read
Business
Espero Pharma Announces Promotion Of Nitrolingual Pumpspray (Nitroglycerin Lingual Spray)
April 6, 2016
 · 
2 min read
Load More
JOBS